Fulgent Genetics Inc (FLGT)
92.04
+2.54 +2.84%
NASDAQ
Jul 26, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 773.39M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 14.80 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 416.96M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 79.39% |
| Profit Margin (Quarterly) | 55.84% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 2.670B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 3.096 |
| PE Ratio | 6.219 |
| Price to Book Value | 3.330 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.0188 |
| Free Cash Flow (Quarterly) | 221.69M |
| Return on Equity | Upgrade |
View All FLGT News
News
-
WireHeadlineTime (ET)
-
Yahoo07/26 10:59
-
Yahoo07/26 08:24
-
Yahoo07/19 16:45
-
Yahoo07/14 08:22
-
Yahoo07/13 09:48
-
Yahoo07/04 05:20
-
SA Breaking News07/01 10:48
-
Yahoo06/29 06:08
-
Yahoo06/28 13:25
-
Yahoo06/24 07:05
-
Yahoo06/22 19:15
-
Yahoo06/22 19:08
-
Yahoo06/22 15:40
-
Yahoo06/22 14:10
-
Yahoo06/22 11:42
-
Yahoo06/22 09:45
-
Yahoo06/22 05:34
-
Yahoo06/21 15:11
-
Yahoo06/21 13:30
-
Yahoo06/21 13:30
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 08/04/2021 | Earnings Results | Q2 2021 Earnings Results |
| 08/04/2021 16:30 EST | Earnings Calls | Q2 2021 Earnings Call |
| 05/06/2021 | Earnings Results | Q1 2021 Earnings Results |
| 05/06/2021 16:30 EST | Earnings Calls | Q1 2021 Earnings Call |
| 03/04/2021 | Earnings Results | Q4 2020 Earnings Results |
| 03/04/2021 16:30 EST | Earnings Calls | Q4 2020 Earnings Call |
| 11/09/2020 | Earnings Results | Q3 2020 Earnings Results |
| 11/09/2020 16:30 EST | Earnings Calls | Q3 2020 Earnings Call |
| 08/04/2020 16:30 EST | Earnings Calls | Q2 2020 Earnings Call |
| 08/04/2020 | Earnings Results | Q2 2020 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; Canada; and Other Countries.
- URL: https://www.fulgentgenetics.com
- Investor Relations URL: https://fulgentgenetics.gcs-web.com
- HQ State/Province: California
- Sector: Healthcare
- Industry: Diagnostics & Research
- Equity Style: Small Cap/Value
- Next Earnings Release: Aug. 04, 2021
- Last Earnings Release: May. 06, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 92.04 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| F000016A1S | FT Top Picks December 2020 F CA | 5.13% |
| PBE | Invesco Dynamic Biotech & Genome ETF | 3.43% |
| F000016TL4 | IVZ Small Cap Core Strategy 2021-2 RE | 2.45% |
| RZG | Invesco S&P SmallCap 600® Pure Gr ETF | 2.42% |
| XHS | SPDR® S&P Health Care Services ETF | 2.29% |
| RYWCX | Rydex S&P SmallCap 600 Pure Growth C | 1.96% |
| JSML | Janus Henderson Small Cap Gr Alpha ETF | 1.89% |
| CALF | Pacer US Small Cap Cash Cows 100 ETF | 1.86% |
| HTEC | Robo Global® Hlthcare Tech & Innovt ETF | 1.56% |
| HIL259 | Hillsdale US Small Cap EqSrs Z CA$ U$H (USD) | 1.07% |
| SSMEX | Crossmark Steward Sm-Md Cp Enh Idx C | 0.50% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- FLGT Tweets Stocktwits
Advertisement
